The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

Samsung Biologics earns A+ ESG grade, ranks among top 1.8% of listed firms

Nov 13, 2026 00:43 (2h ago)

Verifying

Samsung Biologics secured an integrated A+ grade in KCGS’s annual ESG evaluation.
1,087 companies were assessed, with 18 receiving A+ and none receiving S.
Samsung Biologics earned A+ in Environment and Social and A in Governance.